Abstract 6157: PAR2 inhibitors reduce resistance to immunotherapy against cancer
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-6157
Abstract: A pan-cancer meta-analysis showed that Protease-activated receptor 2 (PAR2) is one of the genes most significantly associated with resistance to immune checkpoint blockade (ICB) and T cells dysfunction in cancer patients. PAR2 is also upregulated… read more here.
Keywords: inhibitors reduce; cancer; resistance; par2 ... See more keywords
In HF, SGLT2 inhibitors reduce HF hospitalizations at up to 2 y
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j22-0055
Abstract: SOURCE CITATION Zou X, Shi Q, Vandvik PO, et al. Sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis. Ann Intern Med. 2022;175:851-61. 35404670. read more here.
Keywords: reduce hospitalizations; sglt2 inhibitors; medicine; inhibitors reduce ... See more keywords